Search database
Filter
4880
Text search: medicines
Featured
Language
Document type
2576
789
674
254
199
138
88
68
28
27
22
11
5
Countries
248
191
151
114
110
109
97
96
92
91
87
83
76
75
74
73
72
72
71
65
59
56
50
46
42
41
39
37
36
31
30
29
27
27
26
25
24
23
23
23
23
23
23
22
21
18
16
16
16
16
15
13
13
12
12
11
10
10
9
9
9
9
9
9
8
8
7
7
7
6
6
6
6
5
5
5
5
5
5
5
5
4
4
4
4
4
4
4
4
4
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
734
279
210
158
135
103
92
88
63
34
34
32
31
29
27
26
25
24
23
20
20
20
19
19
19
19
19
19
18
18
17
17
16
16
16
16
15
15
14
14
14
13
13
13
13
12
12
12
11
11
11
11
11
11
11
11
10
10
10
10
10
10
10
10
10
10
10
10
9
9
9
9
9
9
8
8
8
8
8
8
8
8
8
8
8
8
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Publication Years
Category
1995
433
291
203
98
91
56
2
2
2
Toolboxes
379
377
295
289
280
252
154
129
128
111
107
96
96
93
91
78
51
40
20
16
12
11
7
2
1
 Add to my MEDBOX

Facilitating access to medicines and continuity of care for Ukrainian refugees: exceptional response or the promise of more inclusive healthcare for all migrants?

Aljadeeah, S.; Michielsen, J.; Ravinetto, R. et al. (2022) C2
The Ukrainian refugee crisis has received prompt attention not only from concerned citizens outside Ukraine and the United Nations agencies but also from the European Commission (EC). For the first time, the Temporary Protection Directive 2001/55/EC was activated, enabling immediate access to health ... more
 Add to my MEDBOX

Libyan Essential Medicines List - 1st Edition

Government of Libya (2022) C1
The pharmaceutical sector of any nation is responsible for providing society with quality medicines and other pharmaceutical services. According to the World Health Organization (WHO), Pharmaceuticals may constitute as much as 40% of the national he ... more
 Download
  View PDF
 Add to my MEDBOX

Access to NCD medicines: emergent issues during the COVID-19 pandemic and key structural factors
recommended

World Health Organisation (WHO) (2023) C_WHO
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and ... more
 Add to my MEDBOX

Access to controlled medicines for pain management in the WHO South-East Asia Region

World Health Organisation (WHO) (2023) C_WHO
The availability of controlled medicines is crucial for patients requiring palliative care, pain relief and symptom management. Many individuals worldwide, especially in low- and middle-income countries, continue to experience limited access to thes ... more
 Add to my MEDBOX

Blood Pressure Medicines

MedlinePlus National Library of Medicine (2021) CC
On this website you can find information on high blood pressure, how to lower it and how blood pressure medicines work.
 External Link
 Add to my MEDBOX

Access to Cardiovascular Disease and Hypertension Medicines in Developing Countries: An Analysis of Essential Medicine Lists, Price, Availability, and Affordability

Husain, M.J.; Datta, B.K.; Kostova, D. et al. Journal of the American Heart Association (2020) CC
Background Access to medicines is important for long‐term care of cardiovascular diseases and hypertension. This study provides a cross‐country assessment of availability, prices, and affordability of cardiovascular disease and hypertension ... more
 External Link
 Add to my MEDBOX

Access to Heart Failure Medicines in Low- and Middle-Income Countries: An Analysis of Essential Medicines Lists, Availability, Price, and Affordability

Agarwal, A.; Husain, M.J.; Datta, B. et al. Circulation: Heart Failure (2022) CC
Heart failure (HF) is a leading global public health problem with >64 million prevalent cases globally. Patients with HF with reduced ejection fraction (HFrEF) from low- and middle-income countries experience a 22% to 58% higher 1-year mortality rate than those in high-income countries.1 Guideline-d ... more
 Download
  View PDF
 Add to my MEDBOX

Selection of essential medicines for the prevention and treatment of cardiovascular diseases in low and middle income countries

Bazargani, Y.T.; Ugurlu, M.; Leufkens, H.G.M. et al. BMC Cardiovascular Disorders (2018) CC
The incidence and mortality of cardiovascular diseases (CVDs) in low and middle income countries (LMICs) have been increasing, while access to CVDs medicines is suboptimal. We assessed selection of essential ... more
 Add to my MEDBOX

National Essential Medicines List - Tertiary/Quaternary Medication Review Process

Republic of South Africa (2017) CC
Long Acting Muscarinic Antagonists (LAMA) such as tiotropium and glycopyrronium are used in the management of COPD1. They have been shown to improve lung function, quality of life and exercise tolerance. They have also been associated with reduced COPD-related exacerbations, associated hospitalisati ... more
 Add to my MEDBOX

Standard Treatment Guidelines and Essential Medicines List for South Africa; Primary Healthcare Level 2020 Edition; Department of Health: Republic of South Africa

National Department of Health, South Africa National Department of Health, South Africa (2020) CC2
The "Primary Healthcare Standard Treatment Guidelines and Essential Medicines List" by the South African National Department of Health provides evidence-based guidelines for diagnosing and managing common medical conditions at the primary healthcare ... more
 Add to my MEDBOX

Access to NCD medicines: emergent issues during the COVID-19 pandemic and key structural factors 2023

World Health Organization WHO (2023) C_WHO
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and ... more
 External Link
 Add to my MEDBOX

Sources And Prices Of Selected Medicines for Children
recommended

Unicef, WHO (2010) C_WHO
Including Therapeutic Food, Dietary Vitamin and Mineral Supplementation - 2nd edition
 Download
  View PDF
 Add to my MEDBOX

The Interagency List of Essential Medicines for Reproductive Health

WHO (2006) C_WHO
Interagency Guidelines - This revised Interagency List of Essential Medicines for Reproductive Health presents the current international consensus on rational selection of essential reproductive health m ... more
 Download
  View PDF
 Add to my MEDBOX

WHO guidelines on safety monitoring of herbal medicines in pharmacovigilance systems

World Health Organization WHO (2004) C_WHO
Guidelines
 External Link
 Add to my MEDBOX

Newborn Care Videos: Preparing Oral Medicines

Global Health Media Project (2014) CC
 External Link
 Add to my MEDBOX

Interim list of WHO essential medicines necessary to treat Ebola cases based on existing guidelines Version 17 November 2014

World Health Organization (2014) C_WHO
 Download
  View PDF
 Add to my MEDBOX

MDS-3: Managing Access to Medicines and Health Technologies - Chapter 36 - Pharmaceutical supply systems assessment

MSH Management Sciences for Health (MSH) (2012) CC
Pharmaceutical system assessments are useful to diagnose problems, plan major projects and interventions, monitor progress, and compare the performance of one system with that of another. Recent years have seen a growth in demand for such assessments because of the global Fund to Fight AIDS, Tubercu ... more
 Download
  View PDF
 Add to my MEDBOX

MDS-3: Managing Access to Medicines and Health Technologies - Chapter 16 - Managing medicine selection

MSH Management Sciences for Health (MSH) (2012) CC
Chapter 16: Managing medicine selection - Key topics: the concept of essential medicines; selection of essential medicines and development of essential ... more
 Download
  View PDF
 Add to my MEDBOX

What You Should Know About Taking Tuberculosis Medicines

Virginia Department of Health Division of TB Control (2002) CC
 Download
  View PDF
 Add to my MEDBOX

Survey of the Quality of Selected Antimalarial Medicines Circulating in Six Countries of Sub-Saharan Africa
recommended

World Health Organization WHO (2011) C_WHO
The survey aimed at evaluating the quality of selected antimalarials in six countries of sub-Saharan Africa (Cameroon, Ethiopia, Ghana, Kenya, Nigeria and the United Republic of Tanzania). These countries have been supported by WHO to strengthen their regulatory controls o ... more
 Add to my MEDBOX

The Pursuit of Responsible Use of Medicines

Sharing and Learning from Country Experiences (2012) C_WHO
 Add to my MEDBOX

Promoting the rational use of medicines

USAID; SIAPS (2015) C1
 Download
  View PDF
 Add to my MEDBOX

Uganda: National Performance Report on Medicines Management July- September 2015

Ministry of Health, Republic of Uganda (2015) C1
 Download
  View PDF
 Add to my MEDBOX

Nigeria: National Quality Assurance Policy For Medicines and Other Health Products

Federal Ministry of Health, Nigeria (2015) C1
 Download
  View PDF
 Add to my MEDBOX

Nepal: National List of Essential Medicines, 2021
recommended

World Health Organisation (WHO) (2021) C_WHO
6th edition, The NLEM 2021 contains 398 drugs molecules in different therapeutic categories.
 Download
  View PDF
 Add to my MEDBOX

Improving Access to and Appropriate Use of Medicines for Mental Disorders
recommended

Corrado Barbui, Tarun Dua, Kavitha Kolappa et al. World Health Organization and Calouste Gulbenkian Foundation (2017) C_WHO
 Download
  View PDF
 Add to my MEDBOX

Guidelines for The Use of Herbal Medicines in Family Health Care

Ministry of Health Republic of Indonesia (2010) C1
 Download
  View PDF
 Add to my MEDBOX

Guidelines for Cunducting Clinical Trials of Medicines, Food Supplements, Vaccines, and Medical Devices in Sierra Leone

Pharmacy Board Sierra Leone (2014) C1
 Download
  View PDF
 Add to my MEDBOX

Technology and Market Landscape Hepatitis C Medicines, August 2017
recommended

A.Hill, T. Swan and K.Timmermans World Health Organisation (WHO); UNITAID (2017) C_WHO
Direct acting antivirals (DAAs) have revolutionized treatment for hepatitis C. Combi- nations of DAAs can cure infection with HCV in 12 weeks, are highly effective and have limited side-effects. Affordability of DAAs has improved significantly, but access remains lim- i ... more
 Download
  View PDF
 Add to my MEDBOX

GUIDELINES FOR CONDUCTING CLINICAL TRIALS OF MEDICINES, FOOD SUPPLEMENTS, VACCINES AND MEDICAL DEVICES IN GHANA

Food and Drugs Authority (FDA), Ghana (2013) C1
Document No. : FDA/SMC/CTD/GL-CCT/2013/01
 Download
  View PDF
 Add to my MEDBOX

Tanzania: National Guidelines for Monitoring Medicines Safety

Tanzania Food & Drugs Authority (TFDA) (2010) C2
Made under Section 5 (c) of the Tanzania Food, Drugs and Cosmetics Act, 2003 | Second Edition
 Download
  View PDF
 Add to my MEDBOX

SWAZILAND GUIDELINE ON DONATION OF MEDICINES

Ministry of Health, Kingdom of Swaziland (2016) C2
 Download
  View PDF
 Add to my MEDBOX

Selection and Use of Essential Medicines 2021
recommended

World Health Organization WHO (2021) C_WHO
The 23rd meeting of the WHO Expert Committee on Selection and Use of Essential Medicines was coordinated from Geneva, Switzerland, and held virtually from 21 June to 2 July 2021. The Committee considered 88 applications proposing additions, changes ... more
 Download
  View PDF
 Add to my MEDBOX

Guidelines for the appropriate use of herbal medicines

World Health Organization (WHO), Regional Office for the Western Pacific (1998) C_WHO
WHO Regional Publications, Western Pacific Series No. 23
Reports the findings and recommendations of a working group convened to prepare guidelines for the use of herbal medicines in Western Pacific countries. Addressed to national health autho ... more
 Download
  View PDF
 Add to my MEDBOX

LAW ESTABLISHING RWANDA FOOD AND MEDICINES AUTHORITY

Government of Rwanda (2013) C2
Official Gazette No 43 of 28/10/2013 | LAW No 74/2013 OF 11/09/2013 ESTABLISHING RWANDA FOOD AND MEDICINES AUTHORITY AND DETERMINING ITS MISSION, ORGANISATION AND FUNCTIONING
 Download
  View PDF
 Add to my MEDBOX

National Standard Therapeutic Guidelines and Essential Medicines List Liberia 2017, 2nd ed.
recommended

Republic of Libera, Ministry for Health and Social Welfare (2017) C1
 Download
  View PDF
 Add to my MEDBOX

Guidelines on second-and third-line medicines and type of insulin for the control of blood glucose levels in non-pregnant adults with diabetes mellitus

World Health Organization WHO (2018) C_WHO
The new guidelines provide public health guidance on pharmacological agents for managing hyperglycaemia in type 1 and type 2 diabetes for use in primary health-care in low-resource settings. These guidelines update the recommendations for managing hyperglycaemia in the WHO Package of Essential NCD I ... more
 Download
  View PDF
 Add to my MEDBOX

Philippine National Drug Formulary - Essential Medicines List, Volume I (7th Edition)

The National Formulary Committee, National Drug Policy, DOH Philippines (2008) C1
 Download
  View PDF
 Add to my MEDBOX

World Health Organization Model List of Essential Medicines 22st List
recommended

World Health Organization WHO (2021) C_WHO
WHO today published the new edition of its Model Lists of Essential Medicines and Essential Medicines for Children, which include new treatments for various cancers, insulin analogues and new oral ... more
 Download
  View PDF
 Add to my MEDBOX

Standard Treatment Guidelines & National Essential Medicines List Tanzania Mainland

Ministry of Health, Community Development, Gender, Elderly and Children; Government of Tanzania (2018) C1
 External Link
 Add to my MEDBOX

Projected Uptake of New Antiretroviral (ARV) Medicines in Adults in Low- and Middle- Income Countries: A Forecast Analysis 2015- 2025

A. Gupta; S. Juneja; M. Vitoria; et al. PLOS ONE (2016) CC
Research Article PLOS ONE | DOI:10.1371/journal.pone.0164619 October 13, 2016
 Add to my MEDBOX

Statement on herbal remedies and medicines for prevention and treatment of COVID-19

African Union; Africa CDC Centres for Disease Control and Prevention (2020) C1
This statement aims to provide guidance and recommendation to African Union Member States in responding to the following questions: What should countries do when announcing identification of a herbal remedy or medicine? What are the implications for the rest of the continent?
 Download
  View PDF
 Add to my MEDBOX

Guidance for registered pharmacies preparing unlicensed medicines: revison 2018

General Pharmaceutical Council Genral Pharmaceutical Council UK (2018) CC
This guidance should be followed if an unlicensed medicine is prepared in a registered pharmacy. The preparation of an unlicensed medicine (for example unlicensed methadone, or menthol in aqueous cream) in a pharmacy is called ‘extemporaneous preparation’. The guidance should be read alon ... more
 Add to my MEDBOX

Joint request for selected preventive chemotherapy medicines and joint reporting form

World Health Organization WHO (2013) C_WHO
User Guide
 Download
  View PDF
 Add to my MEDBOX

Innovative delivery systems for paediatric medicines

World Health Organization WHO; Unitaid (2020) C_WHO
Technology landscape
 Add to my MEDBOX

Key technical issues of herbal medicines with reference to interaction with other medicines

World Health Organization WHO (2020) C_WHO
 Download
  View PDF
 Add to my MEDBOX

WHO guidance on testing of “suspect” falsified medicines

World Health Organization WHO (2018) C_WHO
Annex 5, WHO Technical Report Series 1010, 2018
 External Link
 Add to my MEDBOX

Pharmacists' knowledge and perceptions about herbal medicines: A case study of Jos and environs

Jimann, N.S.; et al. (2017) CC
Med J DY Patil Univ 2017;10:229-33
 Download
  View PDF
 Add to my MEDBOX

Assessment of access to essential outpatient medicines in Ukraine

World Health Organization WHO, Regional Office of Europe (2021) C_WHO
WHO recently conducted a survey to assess the availability and cost of a national tracer list of essential medicines in the outpatient sector in Ukraine using a new collection tool – the WHO Essential Me ... more
 Add to my MEDBOX

Updates to section 6.2.5 Antituberculosis medicines of the 2021 WHO Model List of Essential Medicines

World Health Organization WHO (2022) C_WHO
 Add to my MEDBOX

Type 2 diabetes in adults: choosing medicines

National Institute for Health and Care Excellence (2022) CC2
Factors to take into account when choosing, reviewing and changing medicines. Rescue therapy: For symptomatic hyperglycaemia, consider insulin or a sulfonylurea and review when blood glucose control has been achieved. Diet and lifestyle advice: ... more
 Add to my MEDBOX

Guidelines on second- and third-line medicines and type of insulin for the control of blood glucose levels in non-pregnant adults with diabetes mellitus - World Health Organization

World Health Organization WHO (2018) C_WHO
Diabetes mellitus (hereafter referred to as diabetes) is a chronic, progressive disease characterized by elevated blood glucose levels. Diabetes can lead to complications such as cardiovascular disease (CVD) and premature death, and can damage eyes, kidneys and nerves. Globally, more than 400 millio ... more
 Add to my MEDBOX

The availability, prices and affordability of essential medicines in Malawi: A cross-sectional study

Khuluza, F.; Haefele-Abah, C. PLoS ONE (2019) CC
The Malawian government recently introduced cost-covering consultation fees for self-referral patients in tertiary public hospitals. Previously, patients received medicines free of charge in government-owned health facilities, but must pay elsewhere ... more
 Add to my MEDBOX

Counterfeit Drugs - Guidelines for the development of measures to combat counterfeit medicines

World Health Organization (1999) CC
These guidelines are aimed to provide guidance to Member States in developing their own national measures to combat counterfeiting of medicines. The guidelines include: an overview of the problems and factors concerning the counterfeiting of ... more
 Download
  View PDF
 Add to my MEDBOX

The World Medcines situation 2011 Rational use of Medicines

World Health Organization WHO (2011) C_WHO
Millennium Development Goal 8E aims for affordable access to essential medicines. Essential medicines, as defined by WHO, are those that “satisfy the health-care needs of the majority of the popul ... more
 Download
  View PDF
 Add to my MEDBOX

Uganda National Communication Strategy for Promoting Rational Use of Medicines

Federal Ministry of Health, Uganda (2009) C1
 Download
  View PDF
 Add to my MEDBOX

WHO Level II household survey to measure access to and use of medicines in Ghana

Daniel Kojo Arhinful Ministry of Health, Ghana (2011) C1
This field study to measure access to and use of medicines was undertaken in GHANA in May-June 2008. The study assessed information on the socio-economic level of households, and access to and use of ... more
 Add to my MEDBOX

A practical handbook on the pharmacovigilance of antiretroviral medicines

World Health Organization WHO (2013) C_WHO
This is a detailed manual giving a step by step approach to undertaking the pharmacovigilance of antiretrovirals. It is intended to be a source of practical advice for Pharmacovigilance Centres and health professionals involved in HIV/AIDS prevention and treatment programmes. A number of WHO publica ... more
 External Link
 Add to my MEDBOX

Health Care Financing in Ethiopia: Implications on Access to Essential Medicines

Eskender Eshetu Ali (2014) CC
Value in Health Regional Issues 4 C (2014) 37-40
 Download
  View PDF
 Add to my MEDBOX

كيف أحصل على الأدوية في ألمانيا؟ - How to Get Medicines in Germany? Arabic version

ABDA - Bundesvereinigung Deutscher Apothekerverbände (2015) C2
short information for migrants on how to access medicines in Germany
 Download
  View PDF
 Add to my MEDBOX

Swaziland: Guidelines on Import and Export Procedures for Medicines

Ministry of Health, Kingdom of Swaziland (2016) C2
 Download
  View PDF
 Add to my MEDBOX

Pharmaceutical Services in Mozambique: foreign aid in public provision of medicines

Sachy, M; Almeida C; Pepe VLE (2018) CC
This article examines the activities of national and international actors in Pharmaceutical Services (PS) in Mozambique from 2007 to 2012, focusing on the public provision of HIV/Aids, malaria and tuberculosis medicines. It describes how PS function ... more
 Download
  View PDF
 Add to my MEDBOX

Health Systems in Action: An eHandbook for Leaders and Managers - CHAPTER 8 - Managing Medicines And Health Products

Malcolm Clark; Andy Barraclough Management Sciences for Health (2010) C1
Full eHandbook under: http://www.msh.org/resources/health-systems-in-action-an-ehandbook-for-leaders-and-managers Effective supply management has the potential to make a powerful contribution to the reliable availability of essential medicines, whi ... more
 External Link
 Add to my MEDBOX

Standard treatment guidelines, essential medicines list , essentia laboratory supplies for Zambia
recommended

Ministry of Health, Zambia (2020) C1
5th edition
 Download
  View PDF
 Add to my MEDBOX

Executive summary: the selection and use of essential medicines 2021

World Health Organization WHO (2021) C_WHO
Report of the 23rd WHO Expert Committee on the selection and use of essential medicines This executive summary reports the recommendations made by the Expert Committee for the 2021 update of the WHO Model List of Essential ... more
 Download
  View PDF
 Add to my MEDBOX

Assessment of a revolving drug fund for essential asthma medicines in Benin

Gildas Agodokpessi, Nadia Aït-Khaled, Martin Gninafon, Leon Tawo, Wilfried Bekou, Christophe Perrin, Karen Bissell, Nils Billo, Donald A Enarson, Chen-Yuan Chiang Journal of Pharmaceutical Policy and Practice (2015) C2
Agodokpessi et al. Journal of Pharmaceutical Policy and Practice (2015) 8:12DOI 10.1186/s40545-015-0033-7 Benin established a revolving drug fund (RDF) for essential asthma medicines in 2008. We evaluated the operation of the RDF and assessed wh ... more
 Download
  View PDF
 Add to my MEDBOX

WHO Regional Office for Europe advice on the use of experimental medicines for the treatment of COVID-19 patients

World Health Organization (Europe) (2020) C_WHO
9 April 2020 WHO has published the guidance “Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected” This document is intended for clinicians taking care of hospitalized adult and paediatric patients with severe acute respiratory infection (SARI) whe ... more
 Download
  View PDF
 Add to my MEDBOX

UNAIDS hails new results showing that long-acting injectable medicines are highly effective in preventing HIV among women

UNAIDS (2020) C_WHO
 External Link
 Add to my MEDBOX

A Concise Quality Control Guide on Essential Drugs and other Medicines

Jähnke, R.W.O. and Kornelia Dwornik (2021) CC
100 test methods for 100 active pharmaceutical ingredients For existing Minilab projects that want to replace old manuals or initiatives that want to start new projects, the new "Minilab Edition 2020" can be obtained at the preferential price of 50 € from our logistic partner Technologie Transfer ... more
 Add to my MEDBOX

A Concise Quality Control Guide on Essential Drugs and other Medicines: COVID-19 Special Issue

Jähnke, R.W.O. and Kornelia Dwornik (2021) CC
Two test methods on dexamethasone tablets and injections
 Add to my MEDBOX

Guidelines on management of blood and blood components as essential medicines

World Health Organization WHO (2017) C_WHO
 Download
  View PDF
 Add to my MEDBOX

Good pharmacopoeial practices: Chapter on monographs on herbal medicines

World Health Organization WHO (2018) C_WHO
Annex 7
 External Link
 Add to my MEDBOX

WHO Global Atlas of Traditional, Complementary and Alternative Medicines. Text and map volume

Bodeker, Gerard, Ong, Chi-Keong, Grundy, Chris, Burford, Gemma, Shein, Kin. et al. (‎2005)‎. WHO global atlas of traditional, complementary and alternative medicine. Kobe, Japa World Health Organization WHO (2005) C_WHO
 Add to my MEDBOX

Ready to Use Therapeutic Food (RUFT) and the WHO Essential Medicines List

CMAM Forum (2018) CC
Severe Acute Malnutrition (SAM) is one of the greatest child survival challenges in the world today and reportedly affects more than 16.2 million children each year1. High impact, proven treatment interventions exist yet sadly approximately only 3.2 million children with SAM have access to treatme ... more
 Add to my MEDBOX

Standard treatment Guidelines & Essential Medicine List. National essential medicines list for Odisha

HEALTH & FAMILY WELFARE DEPARTMENT GOVERNMENT OF ODISHA (2014) C1
Accessed at 25.03.2014
 Download
  View PDF
 Add to my MEDBOX

DR-TB drugs under the microscope: Sources and prices for drug-resistant tuberculosis medicines
recommended

Médecins sans Frontières (2016) C_WHO
4th edition. This report – now in its fourth edition – analyses the barriers and factors affecting access to treatment regimens for drug-resistant tuberculosis (DR-TB), including new and repurposed drugs. We provide detailed pricing profiles of key DR-TB drugs, using manufacturer responses to s ... more
 Add to my MEDBOX

Malawi: Assessment of the Logistics and Supply Chain Management of Anti-TB Medicines

Chana, R USAID (2009) C1
 Download
  View PDF
 Add to my MEDBOX

Availability, prices and affordability of essential medicines in Haiti

Harinder Singh Chahal, Nazaire St. Fort, Lisa Bero Journal of Global Health (2013) CC
 Download
  View PDF
 Add to my MEDBOX

India: Report of the Core-Committee for Revision of National List of Essential Medicines November 2015

Ministry of Health & Family Welfare (MOHFW), Government of India (2015) C1
 Download
  View PDF
 Add to my MEDBOX

Country perceptions for implementation of the new multi-drug resistant TB (MDR-TB) medicines.

F. Brigden; M. Ya Diul; R. H.Crespo, L. Ditiu, A. Kurats, etc al. Stop TB Partnership to reach; Medecins Sans Frontieres (2017) C1
Report: A survey conducted among the 27 high MDR-TB burden countries. March – July 2015 Stop TB Partnership in collaboration with Medecins Sans Frontieres (MSF). Accessed November 2017.
 Download
  View PDF
 Add to my MEDBOX

HEARTS. Technical package for cardiovascular disease management in primary health care. Access to essential medicines and technology

World Health Organization WHO, et al. (2018) C_WHO
Procurement and supply management activities are fundamental to consistent and reliable access to essential medicines and health products. To reduce the impact of CVD, action needs to be taken to improve prevention, diagnosis, care and management of ... more
 Download
  View PDF
 Add to my MEDBOX

WHO implementation tool for monitoring the toxicity of new antiretroviral and antiviral medicines in HIV and viral hepatitis programmes

World Health Organization WHO (2018) C_WHO
 Download
  View PDF
 Add to my MEDBOX

The impact of the COVID-19 response on the supply chain, availability and cost of generic antiretroviral medicines for HIV in low- and middle-income countries

UNAIDS (2020) C_WHO
The objective of this report is to assess the situational landscape during mid-May 2020 surrounding the value chain of the production and distribution of generic antiretroviral medicines in low- and-middle-income countries and to provide recommendat ... more
 External Link
 Add to my MEDBOX

Availability, Affordability, Access, and Pricing of Anti-cancer Medicines in Low- and Middle-Income Countries: A Systematic Review of Literature

Ocran Mattila, P.; R. Ahmad, S.Shahzad Hasan, et al. (2021) C2
Front. Public Health, 30 April 2021 | https://doi.org/10.3389/fpubh.2021.628744
 Add to my MEDBOX

Burden of asthma and chronic obstructive pulmonary disease and access to essential medicines in low-income and middle-income countries

The Lancet Respiratory Medicine (2015) CC2
Demographic and epidemiological transitions are changing the age structure of the population and the most common diseases. Non-communicable respiratory diseases are an increasing problem at both ends of the age range in low-income and middle-income countries. In children, who represent a large propo ... more
 Download
  View PDF
 Add to my MEDBOX

Ethnobotanical study and conservation status of local medicinal plants: Towards a repository and monograph of herbal medicines in Lesotho

Mugomeri, Eltony; Chatanga, Peter; Raditladi, Tirelo et al. (2016) CC
Afr J Tradit Complement Altern Med. (2013) 10(5):210-229
Plants are important sources of medicines. Herbal medicines in Lesotho are exposed to excessive exploitation and habitat destruction. C ... more
 Add to my MEDBOX

المراكز الأفريقية لمكافحة الأمراض والوقاية منها بيان حول العلاجات والأدوية العشبية Statement on herbal remedies and medicines for prevention and treatment of Covid-19

African Union; Africa CDC Centres for Disease Control and Prevention (2020) C1
تقوم الأدوية التقليدية أو الأدوية النباتية المعتمدة على الأعشاب بدور كأدوية بديلة. عليه، فإنه من المهم ٍ واسعٍم على نطاقَستخدُالأمراض في إفريقيا وتتقييم كلٍّ من س ... more
 Add to my MEDBOX

Ukraine: Humanitarians bring water, food, medicines and other essential supplies for thousands of people in Kherson

United Nations Office for the Coordination of Humanitarian Affairs (OCHA) Reliefweb OCHA Services (2022) C2
(Kherson, 14 November 2022) This morning, the United Nations, led by Humanitarian Coordinator Denise Brown, delivered supplies to help thousands of civilians in the city of Kherson. in southern Ukraine, less than 72 hours after the Government of Ukraine regained control of the city. This is the firs ... more
 Add to my MEDBOX

The availability, cost, and affordability of essential medicines for asthma and COPD in low-income and middle-income countries: a systematic review

Stolbrink, M.; Thomson, H.; Hadfield, R.M. et al. The Lancet Global Health (2022) CC
Background: Asthma and chronic obstructive pulmonary disease (COPD) cause a considerable burden of morbidity and mortality in low-income and middle-income countries (LMICs). Access to safe, effective, quality-assured, and affordable essential medicines ... more
 Add to my MEDBOX

Second-Line Antituberculosis Drugs in Children: A Commissioned Review for the World Health Organization 19th Expert Committee on the Selection and Use of Essential Medicines

Malgosia Grzemska, Elizabeth Mathai World Health Organization WHO (2013)
 Download
  View PDF
 Add to my MEDBOX

Zimbabwe National Pharmacovigilance Policy Handbook, 2nd ed.

Medicines Control Authority of Zimbabwe (MCAZ) | Ministry of Health and Child Care (2016) C2
The Zimbabwe National Pharmacovigilance Policy Handbook, 2nd Edition updates the November 2013 version to indicate the Zimbabwe National Pharmacovigilance (PV) Centre’s compliance with the WHO Pharmacovigilance Indicators Handbook 2015.
 Download
  View PDF
 Add to my MEDBOX

GUIDELINES FOR GOOD CLINICAL TRIAL PRACTICE IN ZIMBABWE

Medicines Control Authority of Zimbabwe (MCAZ) (2012) C2
 Download
  View PDF
 Add to my MEDBOX

GUIDELINE ON SUBMISSION OF DOCUMENTATION FOR REGISTRATION OF A MULTISOURCE (GENERIC) FINISHED PHARMACEUTICAL PRODUCT (FPP): QUALITY PART IN THE COMMON TECHNICAL DOCUMENT (CTD) FORMAT

Medicines Control Authority of Zimbabwe (MCAZ) (2012) C2
 Download
  View PDF
 Add to my MEDBOX

South African National TB Guidelines - Children

Medicines Information Centre; SPES Bona; National HIV & TB Health Care Worker Hotline (2019) C2
Accessed: 08.10.2019 Based on the National Guidelines for the Management of Tuberculosis in Children 2013, Department of Health, South Africa.
 Add to my MEDBOX

Information for Healthcare Professionals on COVID-19 Vaccine AstraZeneca

Medicines and Healthcare products Regulatory Agency (MHRA) UK (2021) CC
REG 174 INFORMATION FOR UK HEALTHCARE PROFESSIONALS
 Add to my MEDBOX

Medicinal products under development for the treatment of Ebola

European Medicines Agency EMA (2014)
Interim Assessement Report The EMA review was started by the Agency’s Committee for Medicinal Products for Human Use (CHMP) to support decision-making by health authorities. This first interim report includes information on seven experimental medicines ... more
 Add to my MEDBOX

Guideline for Application to conduct Clinical Trials in Liberia

Liberia Medicines and Health Products Regulatory Authority (LMHRA) (2014) C1
 Download
  View PDF
 Add to my MEDBOX

Summary of product charakteristics - annex 1

European Medicines Agency (2017) C2
Accessed November 2017
 Download
  View PDF
 Add to my MEDBOX

A Guide to the Registration, Licensing and Scheduling of Medicinal Products in Malawi

Pharmacy, Medicines and Poisons Board, Malawi (2002) C2
First edition, November 1997 | Revised July 2002
 Download
  View PDF
 Add to my MEDBOX

GUIDELINES FOR DISPENSING PREMISES (Malawi)

Pharmacy, Medicines & Poisons Board, Malawi (2015) C2
PMPB/INS-GUIDE/01